NOVA LEAP HEALTH CORP (NLH.CA) Stock Analyst Earnings Estimates
TSX-V:NLH - TSX Venture Exchange - CA66980G1090 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 28.205M 32.55% | 26.179M -7.18% | 25.761M -1.60% | |
| EBITDA YoY % growth | 293.8K 179.43% | 1.345M 357.90% | 1.447M 7.59% | |
| EBIT YoY % growth | -1.062M 13.75% | 460.2K 143.33% | 863.7K 87.68% | |
| Operating Margin | -3.77% | 1.76% | 3.35% | |
| EPS YoY % growth | -0.01 -121.62% | -0.01 -12.50% | N/A 214.44% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 100.00% | 0.00 | % | |
| Q3 2024 Q2Q % growth | -100.00% | 0.00 | % | |
| Q1 2024 Q2Q % growth | 0.01 266.67% | 0.00 | 0.01 | % |
| Q4 2023 Q2Q % growth | -0.01 | 0.00 | -0.01 | % |
| Q3 2023 Q2Q % growth | 0.00 -42.86% | 0.00 | 0.00 | % |
| Q1 2023 Q2Q % growth | 0.00 40.00% | 0.00 | 0.00 | % |
| Q4 2022 Q2Q % growth | -0.01 23.08% | 0.03 | -0.04 | -138.04% |
| Q3 2022 Q2Q % growth | 0.01 -72.00% | 0.00 | 0.01 | % |
| Q2 2022 Q2Q % growth | 0.00 -100.00% | 0.01 | -0.01 | -100.00% |
| Q1 2022 Q2Q % growth | -0.01 -138.46% | 0.00 | -0.01 | % |
| Q4 2021 Q2Q % growth | -0.01 | 0.02 | -0.03 | -163.11% |
| Q2 2021 Q2Q % growth | 0.01 | 0.00 | 0.01 | 482.52% |
| Q1 2021 Q2Q % growth | 0.01 | 0.00 | 0.01 | 1,362.14% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 7.094M 10.33% | % | ||
| Q4 2024 Q2Q % growth | 6.586M -26.16% | 7.313M | -727.2K | -9.94% |
| Q3 2024 Q2Q % growth | 6.407M -2.25% | 6.798M | -391.5K | -5.76% |
| Q2 2024 Q2Q % growth | 6.339M -5.08% | 9.148M | -2.81M | -30.71% |
| Q1 2024 Q2Q % growth | 6.43M 0.53% | 8.871M | -2.441M | -27.52% |
| Q4 2023 Q2Q % growth | 8.919M 31.55% | 12.087M | -3.168M | -26.21% |
| Q3 2023 Q2Q % growth | 6.554M -8.23% | 10.036M | -3.482M | -34.70% |
| Q2 2023 Q2Q % growth | 6.677M -4.43% | 9.211M | -2.534M | -27.51% |
| Q1 2023 Q2Q % growth | 6.396M -12.34% | 9.242M | -2.846M | -30.79% |
| Q4 2022 Q2Q % growth | 6.78M 14.72% | 9.332M | -2.552M | -27.35% |
| Q3 2022 Q2Q % growth | 7.142M 35.69% | 9.201M | -2.059M | -22.38% |
| Q2 2022 Q2Q % growth | 6.987M 37.39% | 9.947M | -2.96M | -29.76% |
| Q1 2022 Q2Q % growth | 7.297M 45.35% | 9.309M | -2.012M | -21.62% |
| Q4 2021 Q2Q % growth | 5.91M 31.82% | 7.377M | -1.467M | -19.88% |
| Q3 2021 Q2Q % growth | 5.263M 24.39% | 6.18M | -916.8K | -14.83% |
| Q2 2021 Q2Q % growth | 5.086M 27.67% | 5.665M | -579.5K | -10.23% |
| Q1 2021 Q2Q % growth | 5.02M 8.87% | 5.253M | -232.9K | -4.43% |
| Q4 2020 Q2Q % growth | 4.484M -6.96% | % | ||
| Q3 2020 Q2Q % growth | 4.231M -4.36% | % | ||
| Q2 2020 Q2Q % growth | 3.983M -6.27% | % | ||
| Q1 2020 Q2Q % growth | 4.611M 17.87% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |